Sleep Medication Market Report 2026

Sleep Medication Market Overview

• Sleep Medication market size has reached to $25.92 billion in 2025 • Expected to grow to $38.05 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Increasing Prevalence Of Mental Illness Fueling The Growth Of The Market Due To Rising Chronic Stress And Disrupted Sleep Patterns • Market Trend: Novel OSA Therapy Reinforces Focus On Obesity-Linked Sleep Disorders • North America was the largest region in 2025.

What Is Covered Under Sleep Medication Market?

Sleep medication refers to pharmaceutical drugs designed to help individuals fall asleep faster, stay asleep longer, or improve overall sleep quality. The primary purpose of sleep medication is to treat sleep disorders such as insomnia by regulating the sleep-wake cycle. The main types of sleep medication include prescription-based drugs, and over-the-counter (OTC) drugs. Prescription-based drugs are medications that require a doctor’s prescription for purchase and use due to their potency, potential side effects, or need for medical supervision. The different types of sleep disorders are insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking and others, and is classified as benzodiazepines, antidepressants, antihistamines, sedating antipsychotics, and others. It is distributed through hospital pharmacy, online pharmacy and retail pharmacy, serving key end-users such as hospitals, homecare, specialty centers and others.

What Is The Sleep Medication Market Growth Forecast?

The sleep medication market size is expected to see strong growth in the next few years. It will grow to $38.05 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to development of orexin receptor antagonists, rising use of melatonin receptor agonists, growth in otc sleep supplements, expansion of homecare and speciality sleep centres, increasing telemedicine and online pharmacy adoption. Major trends in the forecast period include rising prevalence of sleep disorders globally, increased adoption of non-benzodiazepine hypnotics, growth in herbal and dietary sleep supplements, expansion of online pharmacy distribution channels, rising awareness about sleep health and wellness.

Global Sleep Medication Market Segmentation

1) By Type: Prescription-Based Drugs, Over-The-Counter (OTC) Drugs 2) By Sleep Disorder Type: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking, Other Sleep Disorders 3) By Drug Class: Benzodiazepines, Antidepressants, Antihistamines, Sedating Antipsychotics, Other Drug Classes 4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 5) By End-Users: Hospitals, Homecare, Speciality Centres, Other End-Users Subsegments: 1) By Prescription-Based Drugs: Benzodiazepines, Non-Benzodiazepine Hypnotics, Melatonin Receptor Agonists, Orexin Receptor Antagonists, Antidepressants, Antipsychotics, Antihistamines 2) By Over-The-Counter (OTC) Drugs: Antihistamines, Melatonin Supplements, Herbal Supplements, Dietary Supplements

What Is The Driver Of The Sleep Medication Market?

The increasing prevalence of mental illness is expected to propel the growth of the sleep medication market going forward. Mental illness refers to a wide range of mental health conditions that affect a person’s mood, thinking, behavior, and overall functioning. The prevalence of mental illness is increasing due to rising levels of chronic stress, as prolonged stress disrupts brain function and triggers or worsens mental health disorders. Sleep medication aids in mental illness by improving sleep quality, which is often disrupted in mental health conditions. They help regulate the sleep-wake cycle, reducing symptoms like insomnia and anxiety, thereby enhancing overall mental well-being and daily functioning. For instance, in 2025, according to the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, US-based health agencies reported that serious mental illness (SMI) prevalence was about 5.44% in 2023 and remained close by 2024 at about 5.6% of adults, indicating stability in that severe category. Therefore, the increasing prevalence of mental illness is driving the growth of the sleep medication industry.

Key Players In The Global Sleep Medication Market

Major companies operating in the sleep medication market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Perrigo Company plc, H. Lundbeck A/S, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Vanda Pharmaceuticals Inc., Natrol LLC

Global Sleep Medication Market Trends and Insights

Major companies operating in the sleep medication market are focusing on developing innovative products, such as those for moderate-to-severe obstructive sleep apnea, to expand their therapeutic portfolios and meet the rising demand for advanced sleep disorder solutions. Moderate-to-severe obstructive sleep apnea refers to a serious sleep disorder in which repeated airway blockages during sleep cause frequent breathing interruptions, significantly reducing oxygen levels and disrupting overall sleep quality. For instance, in December 2024, Eli Lilly and Company, a U.S.-based pharmaceutical company, announced that the U.S. FDA has approved Zepbound (tirzepatide) as the first prescription therapy specifically indicated for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Designed to be used alongside calorie reduction and increased physical activity, Zepbound offers a new pharmacological option to improve OSA outcomes. The approval highlights the growing clinical need for effective OSA treatments, a condition often underestimated despite its significant impact on sleep quality, daytime functioning, and overall health.

What Are Latest Mergers And Acquisitions In The Sleep Medication Market?

In July 2024, Cosette Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Ambien (zolpidem tartrate) (a fast-acting sleep medication) and Ambien CR tablets (6.25 mg once daily immediately before bedtime) from Sanofi S.A. for an undisclosed amount. With this acquisition, Cosette Pharmaceuticals has significantly expanded its presence in the U.S. sleep medicine market by adding well-established insomnia treatments to its portfolio. Sanofi S.A. is a France-based pharmaceutical company that develops sleep medications.

Regional Insights

North America was the largest region in the sleep medication market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sleep Medication Market?

The sleep medication market consists of sales of hormonal sleep aids, anticonvulsants, cannabinoids, and combination medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sleep Medication Market Report 2026?

The sleep medication market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sleep medication industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.